BAT IT: Banked Anti-SARS Cov-2 T cell Infusions for Treatment of COVID 19 (H-47739)
BAT IT: Banked Anti-SARS Cov-2 T cell Infusions for Treatment of COVID 19
This is a dose-finding safety trial followed by a randomized pilot trial comparing administration of SARS-CoV2-specific T cells (SARS-CoVSTs) to standard of care treatment in hospitalized patients with COVID19 who are at high risk of requiring mechanical ventilation.
The SARS-CoVSTs lines have been made at Baylor College of Medicine from healthy donors who have made a full recovery from COVID19. These cell lines were frozen for later use and will be thawed and used to treat patients who meet the eligibility criteria.
AGE REQUIREMENTS: 18 years and older.
More information about this study can be found on clinicaltrials.gov.